New Online

This cohort study evaluate rates and risk factors associated with breast cancer–related lymphedema in patients treated with axillary lymph node dissection.

This study examines whether the molecular landscape of pediatric thyroid nodules is amenable to detection by a multigene genomic classifier test.

This cross-sectional study assesses disclosures of commercial payer-negotiated rates in compliance with Centers for Medicare & Medicaid Services new final ruling effective January 1, 2022.

This secondary analysis of the Keynote 048 trial examines treatment with pembrolizumab in patients with recurrent and metastatic head and neck squamous cell carcinoma.

This Viewpoint advocates for the inclusion of transgender and nonbinary persons in clinical trials and tumor registries.

This randomized clinical trial examines the efficacy and safety outcomes for patients with hormone receptor–positive, ERBB2–, high-risk early breast cancer enrolled in the randomized clinical trial monarchE who received neoadjuvant chemotherapy.

This case series uses postmarketing data to evaluate the association of daratumumab use with ocular events such as acute angle-closure glaucoma, myopic shift, and choroidal effusions among US adults.

This qualitative study uses interview data to explore clinician perspectives on the function of multidisciplinary tumor boards beyond clinical decision-making.